
News|Articles|January 13, 2026
Nearly Two-Thirds of Women With Perimenopause Symptoms Report Inadequate Clinical Guidance: Daily Dose
Author(s)Sydney Jennings
Fact checked by: Grace Halsey
Your daily dose of the clinical news you may have missed.
Advertisement
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On November 14, 2025, we reported on a national survey that was designed to examine how health care gaps affect women in perimenopause.
The survey
The 2025 "Perimenopause Focus" survey, conducted in August 2025, included 1005 US women ages 30 to 60 who work full or part-time.
The findings
According to the results, 37% of women surveyed reported having proactive and satisfactory conversations about perimenopause with their health care provider, meaning nearly two-thirds failed to get adequate medical guidance throughout this transition, the authors stressed. The breakdown showed:
42% said their primary care provider or OB/GYN had initiated discussions about perimenopause symptoms during regular appointments
37% reported no conversations at all
26% received inadequate or incomplete information
In addition, 85% of respondents did not feel informed and knowledgeable about perimenopause early in this stage. Women were more likely to learn about perimenopause from more readily available sources than a health care professional. When seeking information, 42% of survey respondents turned to Google and 42% tapped family members, while only 26% received information from their primary care provider or OB/GYN.
Authors’ comments
“Perimenopause affects half the population with symptoms that can impact quality of life, mental health, and long-term well-being. The findings from this survey point to a clear and urgent gap in how perimenopause is discussed, diagnosed, and treated in clinical practice.”
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Once-Monthly Mirikizumab-mrkz Regimen for Ulcerative Colitis: Daily Dose
2
FDA Identifies NDA Deficiencies for Anaphylm as Review Continues, Aquestive Therapeutics Announces
3
Weight-Loss Interventions Improve Psoriasis Severity and Quality of Life, Meta-Analysis Finds
4
Implementing Long-Acting PrEP in Primary Care: Workflow Lessons With Kevin Hatfield, MD
5
























































































































































































































































































































